Aigen Investment Management, LP

Position in GILD — Gilead Sciences, Inc.

CIK 1741224 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,788,052

+$1,210,544 QoQ

Shares Held

29,983

+62.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.04%

of 13F equity value

Holder Rank

#649

of 2,266 holders

Holding Since

Dec 2021

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Aigen Investment Management, LP holds $6,988,444 across 5 Drug Manufacturers - General names. GILD ranks #1 (54.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	29,983	$3,788,052
2	LLY	ELI LILLY & Co	1,102	$1,321,771
3	JNJ	Johnson & Johnson	3,601	$914,545
4	SNY	Sanofi	14,359	$612,554
5	NVS	Novartis AG	2,243	$351,522

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,788,052	29,983	+62.1%	Shares	Sole	2026-08-14
2026-03-31	$2,577,508	18,494	+52.9%	Shares	Sole	2026-05-15
2025-03-31	$1,355,580	12,098	-47.3%	Shares	Sole	2025-05-12
2024-03-31	$1,683,138	22,978	+129.3%	Shares	Sole	2024-05-14
2023-09-30	$751,048	10,022	-26.0%	Shares	Sole	2023-11-13
2022-09-30	$835,714	13,547	-90.6%	Shares	Sole	2022-11-09
2021-12-31	$10,459,978	144,057	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.